← FDA Drug Approvals (Drugs@FDA)

STENDRA

NDA · New Drug Application · Sponsor: VIVUS LLC · Approved 2012-04-27

Drug application

FDA Application #

NDA202276

Application type

New Drug Application

Brand name

STENDRA

Generic name

Avanafil

Active ingredients

AVANAFIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

VIVUS LLC

First approval

2012-04-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown